順誠(00531.HK):獨立非執行董事劉紹基遭香港證監會提出研訊程序
格隆匯11月4日丨順誠(00531.HK)公佈,公司理解公司獨立非執行董事劉紹基就香港證監會在市場失當行為審裁處對六名個別人士展開的研訊程序,已被列為該等六名個別人士其中之一。
於證監會日期為2019年10月31日有關研訊程序的新聞稿顯示,研訊程序涉及中國醫療網絡有限公司(前稱中國網絡資本有限公司)("中國網絡")及六名在相關時間擔任中國網絡的董事,包括劉紹基。證監會指稱中國網絡未能於合理及切實可行的情況下儘快披露內幕消息,而該等六名個別人士從事"罔顧後果或疏忽的行為導致"中國網絡涉嫌違規。
劉紹基已告知公司其不同意證監會在研訊程序中對其所作的指稱,並有意對研訊程序竭力抗辯。在此期間,及直至研訊程序完結,研訊程序中並沒有針對其的定論。
研訊程序不涉及該集團,故公司不認為研訊程序會對集團的業務及/或營運帶來任何重大不利影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.